Skip to main content
. 2013 Oct 1;8(10):e76298. doi: 10.1371/journal.pone.0076298

Table 5. Number (%) of patients with adverse events during the 12-week treatment.

PTV ATV
(n = 112) (n = 113)
n (%) n (%)
Adverse drug reaction
Myalgia 1 (0.9) 2 (1.8)
Back pain 2 (1.8) 3 (2.7)
Skin rash 1 (0.9) 0 (0)
Sleep disorder 0 (0) 0 (0)
Anxiety 1 (0.9) 0 (0)
Upper airway infection 4 (3.5) 6 (5.3)
Nasopharyngitis 6 (5.3) 6 (5.3)
Cough 2 (1.8) 5 (4.4)

Data are n (%). PTV vs. ATV: all p-values were > 0.05. Abbreviations: (see Tables 1 & 2).